Exco InTouch

By Jonah Comstock December 11, 2014
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round. The Nottingham, England-based company...
By Aditi Pai June 17, 2014
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD. The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
By Brian Dolan December 17, 2013
At the mHealth Summit outside of Washington, D.C. last week, Mike Shilling, director of business development at Exco InTouch, shared three examples of mobile-enabled clinical trials that recently finished up or are still underway. The trials each leveraged mobiles in different ways and helped highlight a few of the strategies for deploying them in support of a trial as well as the various...
By Jonah Comstock November 1, 2013
Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors. Clinical Ink makes SureSource, a windows-based tablet software for healthcare providers to collect clinical trial data electronically at the point of care. They use Windows tablets because stylus...
By Aditi Pai September 19, 2013
Over the span of two days last week, Voalte, Audax Health and Google made mobile health hires. Over the span of a month, there have been seven total hiring announcements. While Voalte's new hire has a background in health, some, like Audax's addition of Zynga Chief Operating Officer (COO) David Ko was brought on to grow the company in a new way. MobiHealthNews has compiled a list of all the...
By Jonah Comstock March 1, 2013
A screenshot from Exco's clinical trial software. One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD) in the UK using mobile and online tools....
By Jonah Comstock November 20, 2012
The now-defunct Healogica app. Clinical trials are a clear area where mobile engagement and big data have serious potential, but it's still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them. At least one abandoned study and one failed company can attest to those...
By Brian Dolan July 9, 2012
At the DIA Annual Meeting in Philadelphia last month, Vodafone and Exco InTouch announced a deal that sees Vodafone launching a new mobile-enabled clinical trial offering that leverages Exco's patient reported outcomes software for mobile phones. Exco made headlines last year when it inked a deal with pharmaceutical company Pfizer to determine how effective mobile-enabled clinical trials could be...
By Brian Dolan January 19, 2012
In recent months a number of deals, acquisitions, service and product launches have led to a growing discussion around the mobile health opportunities for pharma companies. There seem to be three big ones vying for the top. Is it adding connectivity to clinical trials? Earlier this month research analyst firm Cutting Edge Information (CEI) published a report that suggested pharma companies look...
By Brian Dolan October 3, 2011
London-based Exco InTouch, which is providing Pfizer with the mobile clinical trial technology its using in its REMOTE study, has secured about $4.67 million from Scottish Equity Partners (SEP). Exco plans to use the funds to expand and take advantage of the "significant growth opportunities" in the emerging mobile patient communication market, the company's press release stated. Exco claims to...

Editor's Pick